Short-term Rho-associated kinase inhibitor treatment accelerates primary keratinocyte growth while preserving stem cell characteristics (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.06.28.497914
Publication URI: http://dx.doi.org/10.1101/2022.06.28.497914
Type: Preprint